For all young/old guns invested in Aphrodite, this is my...

For all young/old guns invested in Aphrodite, this is my takeaway.

* Adequate capital raised ( reasonably easy)

*Remuneration kept to a minimum ( some cash and script)

*R & D grants still eligible for 2016.

*Made an operating profit and at balance sheet date had  current assets exceeding liabilities by $1,734,377
(2015  $145,423)

*Options outstanding  35,000,000 @2.5c expire 31/7/17
  40,000,000 @4C   expire  19/8/19

   I am more interested in comparing the old AQQ to the new and improved AQQ.

  To conclude,  AQQ is on a much firmer footing and methodically heading in the right direction IMO........